Interplay between the lung microbiome and lung cancer

Area of Science:

• Microbiology
• Oncology
• Human Health

Background:

• The human microbiome influences health and disease, with dysbiosis linked to various systemic conditions.
• While the gut microbiome's role in digestive cancers is known, the lung microbiome's involvement in lung cancer is less explored.
• Emerging research suggests microbiota dysbiosis may contribute to carcinogenesis via metabolic, inflammatory, or immune pathways.

Purpose of the Study:

• To review current findings on the lung microbiome and lung cancer.
• To discuss potential mechanisms of lung carcinogenesis involving the lung microbiome.
• To explore the impact of the lung microbiome on lung cancer treatment.

Main Methods:

• Literature review of current research on lung microbiome and lung cancer.
• Synthesis of evidence on microbial roles in lung carcinogenesis.
• Discussion of potential therapeutic implications.

Main Results:

• Recent studies indicate correlations between specific microbes, microbiota dysbiosis, and lung cancer development.
• The lung microbiome may influence lung cancer through metabolic, inflammatory, and immune modulation.
• Dysbiosis is implicated in the progression and potentially the initiation of lung cancer.

Conclusions:

• The lung microbiome plays a significant role in lung carcinogenesis.
• Further research into the lung microbiome-lung cancer axis is crucial for developing novel prevention and treatment strategies.
• Understanding this interplay may pave the way for personalized lung cancer therapies.